2021-01-03,b'$NYMX $2.48 -0.05  -1.98%NX-1207 Fexapotide\nBPHNDA Filing 1Q 2021 NDA filing planned 1Q 2021.\n$RGLS $1.35 +0.06  +4.65%RGLS4326\nAutosomal dominant polycystic kidney disease (ADPKD)\nPhase 1 data from the first cohort due 1Q 2021.'
2020-12-28,"b""Rose Above Previous Day's High today: $CMT $ETACU $SPNV $EWD $TMP $GCI $CNSL $WTBA $ANH $DOGZ $ASRV $RZV $RWJ $TWIN $HGLB $NYMX $RYTM $PCTI $AIV $AUVI ... https://t.co/TBYRpvrFqi"""
2021-01-08,b'Still looking good for higher $NYMX https://t.co/gyjgL0DcjB'
